ZMapp (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "ZMapp" in English language version.
refsWebsite
Global rank
English rank
7th place
7th place
18th place
17th place
54th place
48th place
1st place
1st place
2,941st place
2,021st place
4,467th place
2,455th place
low place
low place
344th place
296th place
1,948th place
1,153rd place
99th place
77th place
low place
low place
11th place
8th place
22nd place
19th place
137th place
101st place
5th place
5th place
bloomberg.com
- Shannon Pettypiece for Bloomberg News. 23, October 2014. Cheney in Post 9/11 Era May Be to Thank on Ebola Vaccine
cbc.ca
- Branswell H (21 September 2014). "How a Winnipeg lab became an Ebola research powerhouse". CBC News. The Canadian Press. Retrieved 23 November 2015.
- "Ebola 'cocktail' developed at Canadian and U.S. labs". CBC News. 5 August 2014.
cdc.gov
- "Questions and answers on experimental treatments and vaccines for Ebola". Centers for Disease Control and Prevention. 29 August 2014.
doi.org
- PREVAIL II (13 October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". NEJM. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
- Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. (October 2014). "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp". Nature. 514 (7520): 47–53. Bibcode:2014Natur.514...47Q. doi:10.1038/nature13777. PMC 4214273. PMID 25171469.
- Keller MA, Stiehm ER (October 2000). "Passive immunity in prevention and treatment of infectious diseases". Clin. Microbiol. Rev. 13 (4): 602–14. doi:10.1128/CMR.13.4.602-614.2000. PMC 88952. PMID 11023960.
- Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, et al. (November 2015). "Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies". J. Virol. 89 (21): 10982–92. doi:10.1128/JVI.01490-15. PMC 4621129. PMID 26311869.
- Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, et al. (October 2012). "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques". Proc. Natl. Acad. Sci. U.S.A. 109 (44): 18030–5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
- Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, et al. (November 2013). "Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb". Sci Rep. 3: 3365. Bibcode:2013NatSR...3.3365Q. doi:10.1038/srep03365. PMC 3842534. PMID 24284388.
- Geisbert TW (August 2014). "Medical research: Ebola therapy protects severely ill monkeys". Nature. 514 (7520): 41–43. Bibcode:2014Natur.514...41G. doi:10.1038/nature13746. PMC 4469351. PMID 25171470.
- Whaley KJ, et al. (2012). "Emerging Antibody-based Products". Plant Viral Vectors. Current Topics in Microbiology and Immunology. Vol. 375. pp. 107–26. doi:10.1007/82_2012_240. ISBN 978-3-642-40828-1. PMID 22772797.
- Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, et al. (October 2006). "Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors". Proc. Natl. Acad. Sci. U.S.A. 103 (40): 14701–6. doi:10.1073/pnas.0606631103. PMC 1566189. PMID 16973752.
- McCarthy M (2014). "US signs contract with ZMapp maker to accelerate development of the Ebola drug". BMJ. 349: g5488. doi:10.1136/bmj.g5488. PMID 25189475. S2CID 28961384.
- Bixler SL, Duplantier AJ, Bavari S (2017). "Discovering Drugs for the Treatment of Ebola Virus". Current Treatment Options in Infectious Diseases. 9 (3): 299–317. doi:10.1007/s40506-017-0130-z. ISSN 1534-6250. PMC 5570806. PMID 28890666.
- Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, et al. (October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". N. Engl. J. Med. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
fda.gov
- "FDA Approves First Treatment for Ebola Virus". U.S. Food and Drug Administration (FDA) (Press release). 14 October 2020. Retrieved 14 October 2020.
This article incorporates text from this source, which is in the public domain.
firstwordpharma.com
- "Spain imports US experimental Ebola drug to treat priest evacuated from Liberia with disease". First Word Pharma. 11 August 2014.
forbes.com
- Kroll D (5 August 2014). "Ebola 'Secret Serum': Small Biopharma, The Army, And Big Tobacco". Forbes.
- "How Will We Know If The Ebola Drugs Worked?". Forbes. Retrieved 10 September 2014.
harvard.edu
ui.adsabs.harvard.edu
- Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. (October 2014). "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp". Nature. 514 (7520): 47–53. Bibcode:2014Natur.514...47Q. doi:10.1038/nature13777. PMC 4214273. PMID 25171469.
- Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, et al. (October 2012). "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques". Proc. Natl. Acad. Sci. U.S.A. 109 (44): 18030–5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
- Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, et al. (November 2013). "Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb". Sci Rep. 3: 3365. Bibcode:2013NatSR...3.3365Q. doi:10.1038/srep03365. PMC 3842534. PMID 24284388.
- Geisbert TW (August 2014). "Medical research: Ebola therapy protects severely ill monkeys". Nature. 514 (7520): 41–43. Bibcode:2014Natur.514...41G. doi:10.1038/nature13746. PMC 4469351. PMID 25171470.
journalnow.com
- Daniel F (12 August 2014). "Ebola drug provided for two Americans by Reynolds American subsidiary". Winston-Salem Journal.
latimes.com
- Dixon R (6 August 2014). "Africans, three Ebola experts call for access to trial drug". Los Angeles Times. Johannesburg.
leafbio.com
- "Monoclonal antibody-based filovirus therapeutic licensed to Leaf Biopharmaceutical" (PDF). 15 July 2014. Archived from the original (PDF) on 31 October 2014. Retrieved 26 September 2014.
nationalgeographic.com
phenomena.nationalgeographic.com
- "Magnifection – mass-producing drugs in record time". National Geographic. 16 August 2008. Archived from the original on 23 January 2013. Retrieved 11 September 2014.
nbcnews.com
newrepublic.com
- Till B (9 September 2014). "DARPA may have a way to stop Ebola in its tracks". New Republic.
nih.gov
pubmed.ncbi.nlm.nih.gov
- PREVAIL II (13 October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". NEJM. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
- Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. (October 2014). "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp". Nature. 514 (7520): 47–53. Bibcode:2014Natur.514...47Q. doi:10.1038/nature13777. PMC 4214273. PMID 25171469.
- Keller MA, Stiehm ER (October 2000). "Passive immunity in prevention and treatment of infectious diseases". Clin. Microbiol. Rev. 13 (4): 602–14. doi:10.1128/CMR.13.4.602-614.2000. PMC 88952. PMID 11023960.
- Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, et al. (November 2015). "Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies". J. Virol. 89 (21): 10982–92. doi:10.1128/JVI.01490-15. PMC 4621129. PMID 26311869.
- Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, et al. (October 2012). "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques". Proc. Natl. Acad. Sci. U.S.A. 109 (44): 18030–5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
- Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, et al. (November 2013). "Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb". Sci Rep. 3: 3365. Bibcode:2013NatSR...3.3365Q. doi:10.1038/srep03365. PMC 3842534. PMID 24284388.
- Geisbert TW (August 2014). "Medical research: Ebola therapy protects severely ill monkeys". Nature. 514 (7520): 41–43. Bibcode:2014Natur.514...41G. doi:10.1038/nature13746. PMC 4469351. PMID 25171470.
- Whaley KJ, et al. (2012). "Emerging Antibody-based Products". Plant Viral Vectors. Current Topics in Microbiology and Immunology. Vol. 375. pp. 107–26. doi:10.1007/82_2012_240. ISBN 978-3-642-40828-1. PMID 22772797.
- Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, et al. (October 2006). "Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors". Proc. Natl. Acad. Sci. U.S.A. 103 (40): 14701–6. doi:10.1073/pnas.0606631103. PMC 1566189. PMID 16973752.
- McCarthy M (2014). "US signs contract with ZMapp maker to accelerate development of the Ebola drug". BMJ. 349: g5488. doi:10.1136/bmj.g5488. PMID 25189475. S2CID 28961384.
- Bixler SL, Duplantier AJ, Bavari S (2017). "Discovering Drugs for the Treatment of Ebola Virus". Current Treatment Options in Infectious Diseases. 9 (3): 299–317. doi:10.1007/s40506-017-0130-z. ISSN 1534-6250. PMC 5570806. PMID 28890666.
- Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, et al. (October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". N. Engl. J. Med. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
ncbi.nlm.nih.gov
- PREVAIL II (13 October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". NEJM. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
- Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. (October 2014). "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp". Nature. 514 (7520): 47–53. Bibcode:2014Natur.514...47Q. doi:10.1038/nature13777. PMC 4214273. PMID 25171469.
- Keller MA, Stiehm ER (October 2000). "Passive immunity in prevention and treatment of infectious diseases". Clin. Microbiol. Rev. 13 (4): 602–14. doi:10.1128/CMR.13.4.602-614.2000. PMC 88952. PMID 11023960.
- Davidson E, Bryan C, Fong RH, Barnes T, Pfaff JM, Mabila M, et al. (November 2015). "Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies". J. Virol. 89 (21): 10982–92. doi:10.1128/JVI.01490-15. PMC 4621129. PMID 26311869.
- Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, et al. (October 2012). "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques". Proc. Natl. Acad. Sci. U.S.A. 109 (44): 18030–5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
- Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, et al. (November 2013). "Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb". Sci Rep. 3: 3365. Bibcode:2013NatSR...3.3365Q. doi:10.1038/srep03365. PMC 3842534. PMID 24284388.
- Geisbert TW (August 2014). "Medical research: Ebola therapy protects severely ill monkeys". Nature. 514 (7520): 41–43. Bibcode:2014Natur.514...41G. doi:10.1038/nature13746. PMC 4469351. PMID 25171470.
- Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, et al. (October 2006). "Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors". Proc. Natl. Acad. Sci. U.S.A. 103 (40): 14701–6. doi:10.1073/pnas.0606631103. PMC 1566189. PMID 16973752.
- Bixler SL, Duplantier AJ, Bavari S (2017). "Discovering Drugs for the Treatment of Ebola Virus". Current Treatment Options in Infectious Diseases. 9 (3): 299–317. doi:10.1007/s40506-017-0130-z. ISSN 1534-6250. PMC 5570806. PMID 28890666.
- Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, et al. (October 2016). "A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection". N. Engl. J. Med. 375 (15): 1448–1456. doi:10.1056/NEJMoa1604330. PMC 5086427. PMID 27732819.
niaid.nih.gov
- "Press release: Study Finds Ebola Treatment ZMapp Holds Promise, Although Results Not Definitive". National Institute of Allergy and Infectious Diseases. 12 October 2016.
nih.gov
- "Liberia-U.S. clinical research partnership opens trial to test Ebola treatments". National Institutes of Health (NIH). Retrieved 27 February 2015.
nytimes.com
- Pollack A (8 August 2014). "In Ebola outbreak, who should get experimental drug?". The New York Times.
- Pollack A (29 August 2014). "Experimental Drug Would Help Fight Ebola if Supply Increases, Study Finds". The New York Times. Retrieved 1 September 2014.
- Lai KK (23 October 2014). "Treating Ebola: The Hunt for a Drug". The New York Times. Retrieved 15 November 2017.
- McNeil DG Jr (12 August 2019). "A Cure for Ebola? Two New Treatments Prove Highly Effective in Congo". The New York Times. Retrieved 13 August 2019.
popsci.com
- Parshley L (8 August 2014). "ZMapp: The Experimental Ebola Treatment Explained". Popular Science.
semanticscholar.org
api.semanticscholar.org
- McCarthy M (2014). "US signs contract with ZMapp maker to accelerate development of the Ebola drug". BMJ. 349: g5488. doi:10.1136/bmj.g5488. PMID 25189475. S2CID 28961384.
web.archive.org
- "Monoclonal antibody-based filovirus therapeutic licensed to Leaf Biopharmaceutical" (PDF). 15 July 2014. Archived from the original (PDF) on 31 October 2014. Retrieved 26 September 2014.
- "Magnifection – mass-producing drugs in record time". National Geographic. 16 August 2008. Archived from the original on 23 January 2013. Retrieved 11 September 2014.
who.int
- "Notes for the record: Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions for Ebola Virus Disease (EVD)" (PDF). World Health Organization (WHO). 17 May 2018. Retrieved 25 May 2018.
wired.com
- Molteni M (12 August 2019). "Ebola is Now Curable. Here's How The New Treatments Work". Wired. Retrieved 13 August 2019.
worldcat.org
search.worldcat.org
- Bixler SL, Duplantier AJ, Bavari S (2017). "Discovering Drugs for the Treatment of Ebola Virus". Current Treatment Options in Infectious Diseases. 9 (3): 299–317. doi:10.1007/s40506-017-0130-z. ISSN 1534-6250. PMC 5570806. PMID 28890666.